FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · point in time

4D Molecular Therapeutics, Inc.: common_shares_issued

One fact, its scope and the complete path back to the official record.

Period: as of 2023-03-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/f189ea32-3f9c-45b0-abe9-25d1e05008b9

Reported value

33236768{"unit": "shares", "value": 33236768, "concept": "us-gaap:CommonStockSharesIssued"}
Entity
4D Molecular Therapeutics, Inc.
Metric
common_shares_issued
Period
as of 2023-03-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0000950170-23-020703 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T16:59:42.843269+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001650648/common-shares-issued/2023-03-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.